The Science of Fatty Acids and Inflammation

Advances in Nutrition

Volumn 6, Issue 3, 2015, Pages 293S-301S

  Fritsche, Kevin L ^a  

^a University of Missouri   (United States)

Author keywords

Endotoxin; Fatty Acids; Inflammation; Linoleic Acid; Lipopolysaccharide; Microflora; Omega 3

Indexed keywords

ENDOTOXIN; FAT INTAKE; FATTY ACID;

ADVERSE EFFECTS; ANIMAL; DIET; DISEASE MODEL; FAT INTAKE; HUMAN; IMMUNOLOGY; INFLAMMATION; PHARMACOLOGY;

ANIMALS; DIET; DIETARY FATS; DISEASE MODELS, ANIMAL; ENDOTOXINS; FATTY ACIDS; HUMANS; INFLAMMATION;

EID: 84943660984     PISSN: 21618313     EISSN: 21565376     Source Type: Journal    
DOI: 10.3945/an.114.006940     Document Type: Article

References (65)

1. Henson PM. Dampening inflammation. Nat Immunol 2005;6:1179-81.
2. Nathan C. Points of control in inflammation. Nature 2002;420: 846-52.
3. Nathan C, Ding A. Nonresolving inflammation. Cell 2010;140:871-82.
4. Dandona P, Aljada A, Bandyopadhyay A. Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol 2004; 25:4-7.
5. Perry VH, Cunningham C, Holmes C. Systemic infections and inflammation affect chronic neurodegeneration. Nat Rev Immunol 2007;7: 161-7.
6. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell 2010;140:883-99.
7. Larsen GL, Henson PM. Mediators of inflammation. Annu Rev Immunol 1983;1:335-59.
8. Nikolajczyk BS, Jagannathan-Bogdan M, Denis GV. The outliers become a stampede as immunometabolism reaches a tipping point. Immunol Rev 2012;249:253-75.
9. Mraz M, Haluzik M. The role of adipose tissue immune cells in obesity and low-grade inflammation. J Endocrinol 2014;222:R113-27.
10. Calder PC, Ahluwalia N, Albers R, Bosco N, Bourdet-Sicard R, Haller D, Holgate ST, Jonsson LS, Latulippe ME, Marcos A. A consideration of biomarkers to be used for evaluation of inflammation in human nutritional studies. Br J Nutr 2013;109(Suppl 1):S1-34.
11. Basu A, Devaraj S, Jialal I. Dietary factors that promote or retard inflammation. Arterioscler Thromb Vasc Biol 2006;26:995-1001.
12. Kris-Etherton PM, Innis S, Ammerican DA. Position of the American Dietetic Association and Dietitians of Canada: dietary fatty acids. J Am Diet Assoc 2007;107:1599-611.
13. Trayhurn P, Wood I. Signalling role of adipose tissue: adipokines and inflammation in obesity. Biochem Soc Trans 2005;33:1078-81.
14. Hu FB, Manson JE, Willett WC. Types of dietary fat and risk of coronary heart disease: a critical review. J Am Coll Nutr 2001;20:5-19.
15. Lichtenstein AH, Appel LJ, Brands M, Carnethon M, Daniels S, Franch HA, Franklin B, Kris-Etherton P, Harris WS, Howard B. Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation 2006; 114:82-96.
16. Chowdhury R, Warnakula S, Kunutsor S, Crowe F, Ward HA, Johnson L, Franco OH, Butterworth AS, Forouhi NG, Thompson SG, et al. Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis. Ann Intern Med 2014; 160:398-406.
17. Lee JY, Zhao L, Hwang DH. Modulation of pattern recognition receptor- mediated inflammation and risk of chronic diseases by dietary fatty acids. Nutr Rev 2010;68:38-61.
18. Guarner F, Malagelada J-R. Gut flora in health and disease. Lancet 2003;361:512-9.
19. Rietschel ET, Kirikae T, Schade FU, Mamat U, Schmidt G, Loppnow H, Ulmer AJ, Zahringer U, Seydel U, Di Padova F. Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J 1994;8:217-25.
20. Miller SI, Ernst RK, Bader MW. LPS, TLR4 and infectious disease diversity. Nat Rev Microbiol 2005;3:36-46.
21. Deitch EA. Bacterial translocation of the gut flora. J Trauma 1990;30: S184-89.
22. Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, Neyrinck AM, Fava F, Touhy KM, Chabo C. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007;56:1761-72.
23. Berg RD. Bacterial translocation from the gastrointestinal tract. In: Mechanisms in the pathogenesis of enteric diseases. Vol. 2. Springer Science1Business Media, New York; 1999. p. 11-30.
24. Erridge C. The capacity of foodstuffs to induce innate immune activation of human monocytes in vitro is dependent on food content of stimulants of Toll-like receptors 2 and 4. Br J Nutr 2011;105:15-23.
25. Yu B, Hailman E, Wright SD. Lipopolysaccharide binding protein and soluble CD14 catalyze exchange of phospholipids. J Clin Invest 1997; 99:315-24.
26. Laugerette F, Vors C, Géloën A, Chauvin M-A, Soulage C, Lambert- Porcheron S, Peretti N, Alligier M, Burcelin R, Laville M. Emulsified lipids increase endotoxemia: possible role in early postprandial lowgrade inflammation. J Nutr Biochem 2011;22:53-9.
27. Mani V, Hollis JH, Gabler NK. Dietary oil composition differentially modulates intestinal endotoxin transport and postprandial endotoxemia. Nutr Metab (Lond) 2013;10:6-15.
28. Tousoulis D, Papageorgiou N, Antoniades C, Giolis A, Bouras G, Gounari P, Stefanadi E, Miliou A, Psaltopoulou T, Stefanadis C. Acute effects of different types of oil consumption on endothelial function, oxidative stress status and vascular inflammation in healthy volunteers. Br J Nutr 2010;103:43-9.
29. Voon PT, Ng TKW, Lee VKM, Nesaretnam K. Diets high in palmitic acid (16:0), lauric and myristic acids (12:0+14:0), or oleic acid (18:1) do not alter postprandial or fasting plasma homocysteine and inflammatory markers in healthy Malaysian adults. Am J Clin Nutr 2011;94: 1451-7.
30. Walter J, Ley R. The human gut microbiome: ecology and recent evolutionary changes. Annu Rev Microbiol 2011;65:411-29.
31. Burcelin R, Garidou L, Pomié C, editors. Immuno-microbiota cross and talk: the new paradigm of metabolic diseases. In: Seminars in immunology. Elsevier; 2012.
32. Devkota S, Wang Y, Musch MW, Leone V, Fehlner-Peach H, Nadimpalli A, Antonopoulos DA, Jabri B, Chang EB. Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in IL102/2 mice. Nature 2012;487:104-8.
33. Turnbaugh PJ. Microbiology: fat, bile and gut microbes. Nature 2012; 487:47-8.
34. Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, Takeda Y, Takeda K, Akira S. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the LPS gene product. J Immunol 1999;162:3749-52.
35. Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol 2003;21:335-76.
36. Lee JY, Sohn KH, Rhee SH, Hwang D. Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4. J Biol Chem 2001;276:16683-9.
37. Lee JY, Zhao L, Youn HS, Weatherill AR, Tapping R, Feng L, Lee WH, Fitzgerald KA, Hwang DH. Saturated fatty acid activates but polyunsaturated fatty acid inhibits Toll-like receptor 2 dimerized with Toll-like receptor 6 or 1. J Biol Chem 2004;279:16971-9.
38. Das UN. Essential fatty acids: biochemistry, physiology and pathology. Biotechnol J 2006;1:420-39.
39. Harris WS, Mozaffarian D, Rimm E, Kris-Etherton P, Rudel LL, Appel LJ, Engler MM, Engler MB, Sacks F. Omega-6 fatty acids and risk for cardiovascular disease: a science advisory from the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention. Circulation 2009; 119:902-7.
40. Flock MR, Kris-Etherton PM. Dietary Guidelines for Americans 2010: implications for cardiovascular disease. Curr Atheroscler Rep 2011;13: 499-507.
41. Lands WE. Dietary fat and health: the evidence and the politics of prevention: careful use of dietary fats can improve life and prevent disease. Ann N Y Acad Sci 2005;1055:179-92.
42. Simopoulos AP. Essential fatty acids in health and chronic disease. Am J Clin Nutr 1999;70(Suppl):560S-9S
43. Ramsden CE, Zamora D, Leelarthaepin B, Majchrzak-Hong SF, Faurot KR, Suchindran CM, Ringel A, Davis JM, Hibbeln JR. Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis. BMJ 2013;346;e8707.
44. Johnson GH, Fritsche K. Effect of dietary linoleic acid on markers of inflammation in healthy persons: a systematic review of randomized controlled trials. J Acad Nutr Diet 2012;112(7):1029-41, e15.
45. Baer DJ, Judd JT, Clevidence BA, Tracy RP. Dietary fatty acids affect plasma markers of inflammation in healthy men fed controlled diets: a randomized crossover study. Am J Clin Nutr 2004;79: 969-73.
46. Bjermo H, Iggman D, Kullberg J, Dahlman I, Johansson L, Persson L, Berglund J, Pulkki K, Basu S, Uusitupa M. Effects of n26 PUFAs compared with SFAs on liver fat, lipoproteins, and inflammation in abdominal obesity: a randomized controlled trial. Am J Clin Nutr 2012;95: 1003-12.
47. Rett BS, Whelan J. Increasing dietary linoleic acid does not increase tissue arachidonic acid content in adults consuming Western-type diets: a systematic review. Nutr Metab (Lond) 2011;8:36-51.
48. Dennis EA. Lipidomics joins the omics evolution. Proc Natl Acad Sci USA 2009;106:2089-90.
49. Delmastro-Greenwood M, Freeman BA, Gelhaus Wendell S. Redoxdependent anti-inflammatory signaling actions of unsaturated fatty acids. Ann Rev Physiol 2014;76:79-105.
50. Morisseau C, Hammock BD. Impact of soluble epoxide hydrolase and epoxyeicosanoids on human health. Annu Rev Pharmacol Toxicol 2013; 53:37-58.
51. Wall R, Ross RP, Fitzgerald GF, Stanton C. Fatty acids from fish: the anti-inflammatory potential of long-chain omega-3 fatty acids. Nutr Rev 2010;68:280-9.
52. Hooper L, Thompson RL, Harrison RA, Summerbell CD, Ness AR, Moore HJ, Worthington HV, Durrington PN, Higgins J, Capps NE. Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review. BMJ 2006;332:752-60.
53. Riediger ND, Othman RA, Suh M, Moghadasian MH. A systemic review of the roles of n-3 fatty acids in health and disease. J Am Diet Assoc 2009;109:668-79.
54. Brenna JT. Efficiency of conversion of a-linolenic acid to long chain n-3 fatty acids in man. Curr Opin Clin Nutr Metab Care 2002;5: 127-32.
55. Arterburn LM, Hall EB, Oken H. Distribution, interconversion, and dose response of n23 fatty acids in humans. Am J Clin Nutr 2006; 83(Suppl):1467S-76S.
56. Serhan CN, Chiang N, Van Dyke TE. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 2008;8:349-61.
57. Wong SW, Kwon M-J, Choi AM, Kim H-P, Nakahira K, Hwang DH. Fatty acids modulate Toll-like receptor 4 activation through regulation of receptor dimerization and recruitment into lipid rafts in a reactive oxygen species-dependent manner. J Biol Chem 2009;284: 27384-92.
58. Stillwell W, Shaikh SR, Zerouga M, Siddiqui R, Wassall SR. Docosahexaenoic acid affects cell signaling by altering lipid rafts. Reprod Nutr Dev 2005;45:559-79.
59. Oh DY, Talukdar S, Bae EJ, Imamura T, Morinaga H, Fan W, Li P, Lu WJ, Watkins SM, Olefsky JM. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 2010;142:687-98.
60. Fritsche K. Important differences exist in the dose-response relationship between diet and immune cell fatty acids in humans and rodents. Lipids 2007;42:961-79.
61. Turk HF, Chapkin RS. Membrane lipid raft organization is uniquely modified by n-3 polyunsaturated fatty acids. Prostaglandins Leukot Essent Fatty Acids 2013;88:43-7.
62. Calder PC. Fatty acids and inflammation: the cutting edge between food and pharma. Eur J Pharmacol 2011;668:S50-8.
63. Calder PC. Mechanisms of action of (n-3) fatty acids. J Nutr 2012;142 (Suppl):592S-9S.
64. Seok J, Warren HS, Cuenca AG, Mindrinos MN, Baker HV, Xu W, Richards DR, McDonald-Smith GP, Gao H, Hennessy L. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci USA 2013;110:3507-12.
65. Rittirsch D, Hoesel LM, Ward PA. The disconnect between animal models of sepsis and human sepsis. J Leukoc Biol 2007;81:137-43.